Injectable Drug Slows Deterioration From Pulmonary Hypertension

Key Takeaways

A recently approved injectable significantly stalls health deterioration in patients with pulmonary hypertension

Sotatercept reduced risk of deterioration by 76%

Patients were better able to keep exercising and avoid unexpected hospitalizations

MONDAY, Oct. 6, 2025 (HealthDay News) — A recently approved injectable drug can significantly stall deteriorating health among people newly diagnosed with the most severe form of high blood pressure , a new study says.

Sotatercept reduced patient’s risk of deterioration by 76% due to pulmonary hypertension, or high blood pressure in the heart-to-lung system, researchers reported recently in the New England Journal of Medicine .

Patients treated with sotarecept within the first year after diagnosis proved more likely to mai